Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 10, 2022

SELL
$23.75 - $31.69 $22,016 - $29,376
-927 Reduced 27.38%
2,459 $75,000
Q1 2022

May 16, 2022

BUY
$19.97 - $26.94 $67,618 - $91,218
3,386 New
3,386 $88,000
Q4 2020

Feb 16, 2021

SELL
$15.73 - $21.66 $29,478 - $40,590
-1,874 Closed
0 $0
Q3 2020

Nov 10, 2020

BUY
$13.54 - $26.41 $8,638 - $16,849
638 Added 51.62%
1,874 $32,000
Q2 2020

Aug 13, 2020

BUY
$7.84 - $23.29 $9,690 - $28,786
1,236 New
1,236 $29,000
Q2 2019

Aug 06, 2019

SELL
$10.88 - $17.6 $5,189 - $8,395
-477 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$15.51 - $17.61 $558 - $633
36 Added 8.16%
477 $8,000
Q4 2018

Feb 11, 2019

BUY
$14.52 - $19.72 $6,403 - $8,696
441 New
441 $8,000

Others Institutions Holding VIVO

About MERIDIAN BIOSCIENCE INC


  • Ticker VIVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 43,748,000
  • Description
  • Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...
More about VIVO
Track This Portfolio

Track Altshuler Shaham LTD Portfolio

Follow Altshuler Shaham LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Altshuler Shaham LTD, based on Form 13F filings with the SEC.

News

Stay updated on Altshuler Shaham LTD with notifications on news.